期刊文献+

靶向沉默IGF1R基因miR30-shRNA慢病毒的构建及其抗肝癌细胞生长 被引量:5

Construction of lentiviral vector of microRNA targeting IGF1R gene and its inhibition effect on liver cancer cell growth
原文传递
导出
摘要 目的研究靶向人胰岛素样生长因子1类受体(IGFIR)基因miR30-shRNA慢病毒对肝癌细胞生长的影响。方法针对已经筛选确定的IGF1R基因干扰有效序列,合成靶序列的OligoDNA,退火形成双链DNA,与经XhoI和EcoRI酶切后的pPRIME载体连接产生pPRIME-IGF1R-miR30-shRNA。用后者,psPAX2及pMD2G3质粒共转染包装细胞293T细胞,包装产生慢病毒。慢病毒PRIME-IGF1R-miR30-shRNA大量扩增,氯化铯梯度离心纯化,测病毒滴度。RT-PCR及Western blot检测IGF1R表达,CCK-8法检测细胞生长。结果成功构建PRIME-IGF1R-miR30-shRNA,滴度为4.58×109PFU/mL;该慢病毒能抑制肝癌细胞IGF1R表达及生长。结论IGF1R基因miR30-shRNA慢病毒靶向转染可有效地封闭肝癌细胞的IGF1R表达,降低肝癌细胞的增殖能力,为以IGFIR基因为靶点的肝癌生物治疗的进一步研究奠定了实验基础。 Objective To study the effects of lentiviral vector of microRNA targeting IGF 1 R gene on growth of liver cancer cells. Methods The complementary DNA containing both sense and antisense Oligo DNA of the targeting sequence was designed, synthesized and cloned into the pPRIME vector, named pPRIME-IGFIR-miR30-shRNA. The viruses were propagated on 293T cells. Viruses were purified by CsCI gradient according to standard techniques, and functional PFU titers were determined by plaque assay on 293 cells. The effect of pPRIME-IGFIR-miR30-shRNA on IGFIR expression of Hep3B. SMMC7721 cells was detected by RT-PCR and Western blot. The antitumor potential of PRIME-IGFIR-miR30-shRNA to Hep3B, SMMC7721 cells was evaluated by CCK-8 assay and Tunel. Results PRIME-IGFIR-miR30-shRNA was constructed successfully. Functional PFU titers of pPRIME-IGFIR-miR30-shRNA were 4. 58 ×10^9 pFU/ml. PRIME-IGFIR-miR30-shRNA inhibited IGFIR expression and the proliferation of Hep3 B. SMMC7721 cells. Conclusions PRIME-IGFIR-miR30-shRNA expressing IGFIR-siRNA can inhibit IGFIR expression and may be used for further investigation of gene therapy of liver cancer.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2009年第7期703-707,共5页 China Journal of General Surgery
关键词 肝肿瘤 RNA干扰 受体 IGF1型 慢病毒 Hepatic, Neopasms RNA Interference Receptor, IGF Type 1 Lentivirus
  • 相关文献

参考文献8

  • 1Blum G, Gazit A, Levitzki A. Development of new IGFI receptor kinase inhibitors using catechol mimics [ J ]. Bid Chem, 2003,278 (42) :40442 -40454.
  • 2Zhao J, Pettigrew GJ, Thomas J, et al. HIV-derived lentiviral vectors engineered for regulated transgene expression [J]. Basic Res Cardiol, 2002,97(5) :348 -358.
  • 3Bauer G, Dao MA, Case SS, et al. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors[J]. Mol Ther,2008,16(7) :1308- 1315.
  • 4Baba K, Goto-Koshino Y, Mizukoshi F, et al. Inhibition of the replication of feline immunodeficiency virus by lentiviral vector mediated RNA interference in feline cell lines. J Vet Med Sci, 2008,70(8) :777 -783.
  • 5Zeng Y. Principles of micro-RNA production and maturation [J]. Oncogene, 2006, 25(46) : 6156 -6162.
  • 6VarrO M, Baserga R. limited redundancy of survival singals from the type 1 insulin-like growth factors receptor[ J]. Endoerinology,2001,142:1073 - 1081.
  • 7牛坚,李向农,韩泽广.运用siRNA建立稳定低表达IGF1R基因的肝癌细胞株的实验研究[J].中国普外基础与临床杂志,2007,14(6):679-684. 被引量:6
  • 8牛坚,钱海鑫,李向农,黄健,韩泽广.RNA干涉胰岛素样生长因子1类受体的研究[J].中华实验外科杂志,2006,23(7):872-872. 被引量:19

二级参考文献21

  • 1李臣宾 ,张峰 ,史玉荣 ,魏熙胤 ,杨毅 ,牛瑞芳 .小干扰RNA引发多药耐药乳腺癌细胞内MDR1基因沉默的研究[J].中华实验外科杂志,2004,21(10):1199-1201. 被引量:18
  • 2吕伟,张超.RNAi在大肠癌基因治疗中的应用策略和展望[J].中国普外基础与临床杂志,2005,12(6):637-640. 被引量:1
  • 3牛坚,钱海鑫,李向农,黄健,韩泽广.RNA干涉胰岛素样生长因子1类受体的研究[J].中华实验外科杂志,2006,23(7):872-872. 被引量:19
  • 4陈华,景在平,包俊敏,曲乐丰,冯翔,程小星,扬忠.RNA干扰对兔血管平滑肌细胞bcl-2基因表达的影响[J].中国普外基础与临床杂志,2007,14(1):56-58. 被引量:4
  • 5Morriohe A, DeAngelis T, Baserga R. Failure of the bovine papillomavirus to transform mouse emlbryo fibroblasts with a targetded diswruption of theinsulin-like growth factor 1 receptor gene. Surg, 1995, 69 : 5300-5303.
  • 6Russell WE, Van Wyk J J, Pledger WJ. Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedinC[J]. Proc Natl Acad Sci USA, 1984; 81(8):2389
  • 7Blakesley VA, Koval AP, Stannard BS, et al. Replacement of tyrosine 1251 in the carhoxyl terminus of the insulin like growth factor-Ⅰ receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth[J]. J Biol Chem, 1998, 273(29): 18411
  • 8Valentinis B, Baserga R. 1GF-Ⅰ receptor signalling in transfor mation and differentiation[J]. Mol Pathol, 2001, 54(3):133
  • 9Hellawell GO, Turner GD, Davies DR, etal. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease[J]. Cancer Res, 2002,62(10):2942
  • 10Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science, 2002; 296(5567) : 550

共引文献21

同被引文献85

  • 1黄文广,李杰,王峰,程波,田元,张景辉.维甲酸诱导肝癌细胞株凋亡及其与midkine基因表达关系的研究[J].中国普通外科杂志,2004,13(10):783-785. 被引量:5
  • 2常世敏,张智强.浅谈维生素A代谢与生理功能[J].中国食物与营养,2005,11(2):55-57. 被引量:30
  • 3徐涛,陈孝平,黄志勇,李丹,卢凌,张万广.纳米材料栓塞对肿瘤组织表达CD147影响的研究[J].中国普通外科杂志,2007,16(3):213-217. 被引量:2
  • 4Kim JH, Cho YH, Park YL, et al. Prognostic significance of insulin growth factor-I receptor and insulin growth factor binding protein-3 expression in primary breast cancer [ J ]. Oncol Rep,2010,23 (4) :989 -995.
  • 5Sichani MM, Yazdi FS, Moghaddam NA, et al. Prognostic value of insulin-like growth factor-I receptor expression in renal cell carcinoma [ J]. Saudi J Kidney Dis Transpl, 2010, 21(1):69-74.
  • 6An Y, Cai L, Wang Y, et al. Local expression of insulin- like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancer [ J ]. Onkologie, 2009,32(11) :638 -644.
  • 7Gualco E, Wang JY, Del Valle L, et al. IGF-IR in neuroprotection and brain tumors [ J ]. Front Biosci, 2009, 1 (14) :352 -375.
  • 8Yavari K, Taghikhani M, Ghannadi Maragheh M, et al. Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells[ J] . Int J Colorectal Dis, 2010, 25 ( 1 ) :9 - 16.
  • 9Yavari K, Taghikhani M, Maragheh MG, et al. Knockdown of IGF-IR by RNAi inhibits SW480 colon cancer cells growth in vitro[J]. Arch Med Res, 2009,40(4) :235 -240.
  • 10Shukla S, Gupta S. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study [ J ]. Mol Carcinog, 2009,48 (3) : 243 - 52.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部